RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ:GCTK), a medical device company specializing in diabetes care technology, has ...

The Company's Board of Directors approved the reverse stock split at a ratio of 1-for-150 shares on January 25, 2025, following approval for the action by Crown's stockholders at a special ...

Anxiety over a Chinese startup’s threat to American artificial intelligence dominance faded further Wednesday as investors turned their focus to the Federal Reserve’s rate decision due later in the da ...

Brett R. Hagen, the Chief Accounting Officer of Allovir, Inc. (NASDAQ:ALVR), a company with a market capitalization of $49.2 ...

Issuance of common stock refers to the process by which a company sells its shares to investors to raise capital. Common stock represents ownership in the company, granting shareholders voting ...

SAN FRANCISCO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on ...

Focus Universal inc. (Nasdaq:FCUV) (”Focus” or the “Company”), a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G, announces that its board of ...

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

The Company is assessing whether to appeal this determination and expects trading of its common stock will resume on the OTCQX market under its ticker symbol "DNMR" on December 31, 2024.

MicroStrategy, a business intelligence and Bitcoin-focused company, plans to offer 2.5 million shares of preferred stock to ...